Concord Drugs Ltd.
| BSE: 538965 |
Sector: Health care |
| NSE: N.A. |
ISIN Code: INE858L01010 |
|
BSE
00:00 | 24 Apr 2020
|
Concord Drugs Ltd
|
|
NSE
05:30 | 01 Jan 1970
|
Concord Drugs Ltd
|
Notice: Undefined property: stdClass::$market_capital_for_nse in
/usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line
17
| OPEN |
18.45 |
| PREVIOUS CLOSE |
18.45 |
| VOLUME |
2564 |
| 52-Week high |
23.15 |
| 52-Week low |
11.68 |
| P/E |
32.23 |
| Mkt Cap.(Rs cr) |
14 |
| Buy Price |
17.65 |
| Buy Qty |
15.00 |
| Sell Price |
18.99 |
| Sell Qty |
192.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
32.23 |
| Mkt Cap.(Rs cr) |
0 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
| OPEN |
18.45 |
| CLOSE |
18.45 |
| VOLUME |
2564 |
| 52-Week high |
23.15 |
| 52-Week low |
11.68 |
| P/E |
32.23 |
| Mkt Cap.(Rs cr) |
14 |
| Buy Price |
17.65 |
| Buy Qty |
15.00 |
| Sell Price |
18.99 |
| Sell Qty |
192.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
0.00 |
| 52-Week low |
0.00 |
| P/E |
32.23 |
| Mkt Cap.(Rs cr) |
14 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
Concord Drugs Ltd. (CONCORDDRUGS) - Company History
|
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilities for Liquid Injections Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.The company operates a state of the art cGMP contract manufacturing Formulation-Fill-Finish facility providing comprehensive pharmaceutical development and manufacturing services for drug products.The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.
|
Quick Links for Concord Drugs:
Notice: Undefined variable: mediaAbsUrl in
/usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line
6491
